Status:
NOT_YET_RECRUITING
I-PRF After Arthrocentesis Plus Botox Injection to Lateral Pterygoid Muscle in Treatment of Anterior Disc Displacement
Lead Sponsor:
Fayoum University
Conditions:
TMJ Disc Disorder
TMJ Pain
Eligibility:
All Genders
16-45 years
Phase:
NA
Brief Summary
Aim of Study : To evaluate the efficacy of TMJ arhtrocentesis followed by injection of liquid platelet rich fibrin (I-PRF ) in addition to intramuscular injection of lateral pterygoid muscle with botu...
Eligibility Criteria
Inclusion
- Patients with painful tmj during jaw movements
- Patients with joint sounds ( clicking ) during jaw opening and mastication
- Patients age range from 16 years old to 45 years old
- Patients with Class I maxillo-mandibular relationship
- Patients with reduced mouth opening
- All patients diagnosed clinically and radiographically by MRI as TMJ anterior disc displacement with reduction
Exclusion
- Patient with history of recent trauma
- Patients with malocclusion
- Patients with systematic condition that affect bone and joints such as osteoarthritis , systemic lupus and epilepsy .
- Patients allergic to botox injection
- Pregnant or lactating females
- Patients with non-reducible disc on MRI
- Patients contraindicated to exposure to MRI
- Patients with previous tmj arthrocentesis , arthroscopy or TMJ surgery
- Significant mechanical obstruction that prevents mouth opening, acute capsulitis, benign or malignant temporomandibular joint lesions.
- Patients with blood diseases, and coagulation disorders
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06207955
Start Date
February 1 2024
End Date
May 1 2025
Last Update
January 17 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.